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STUDY QUESTION: Do the long-term health outcomes following IVF differ depending upon the duration of embryo culture before
transfer?
SUMMARY ANSWER: Using a mouse model, we demonstrate that in male but not female offspring, adverse cardiovascular (CV) health
was more likely with prolonged culture to the blastocyst stage, but metabolic dysfunction was more likely if embryo transfer (ET) occurred
at the early cleavage stage.
WHAT IS KNOWN ALREADY: ART associate with increased risk of adverse CV and metabolic health in offspring, and these findings
have been confirmed in animal models in the absence of parental infertility issues. It is unclear which specific ART treatments may cause
these risks. There is increasing use of blastocyst, versus cleavage-stage, transfer in clinical ART which does not appear to impair perinatal
health of children born, but the longer-term health implications are unknown.
STUDY DESIGN, SIZE, DURATION: Five mouse groups were generated comprising: (i) natural mating (NM)—naturally mated, non-
superovulated and undisturbed gestation; (ii) IV-ET-2Cell—in-vivo derived two-cell embryos collected from superovulated mothers, with
immediate ET to recipients; (iii) IVF-ET-2Cell—IVF generated embryos, from oocytes from superovulated mothers, cultured to the two-
cell stage before ET to recipients; (iv) IV-ET-BL—in-vivo derived blastocysts collected from superovulated mothers, with immediate ET to
recipients; (v) IVF-ET-BL—IVF generated embryos, from oocytes from superovulated mothers, cultured to the blastocyst stage before ET
to recipients. Both male and female offspring were analysed for growth, CV and metabolic markers of health. There were 8–13 litters gen-
erated for each group for analyses; postnatal data were analysed by multilevel random effects regression to take account of between-
mother and within-mother variation and litter size.
PARTICIPANTS/MATERIALS, SETTINGS, METHODS: C57/BL6 female mice (3–4 weeks old) were used for oocyte production;
CBA males for sperm with human tubal fluid medium were used for IVF. Embryos were transferred (ET) to MF1 pseudo-pregnant recipi-
ents at the two-cell stage or cultured in synthetic oviductal medium enriched with potassium medium to the blastocyst stage before ET.
Control in-vivo embryos from C57BL6  CBA matings were collected and immediately transferred at the two-cell or blastocyst stage.
Postnatal assays included growth rate up to 27 weeks; systolic blood pressure (SBP) at 9, 15 and 21 weeks; lung and serum angiotensin-
converting enzyme (ACE) activity at time of cull (27 weeks); glucose tolerance test (GTT; 27 weeks); basal glucose and insulin levels
(27 weeks); and lipid accumulation in liver cryosections using Oil Red O imaging (27 weeks).
VC The Author(s) 2020. Published by Oxford University Press on behalf of European Society of Human Reproduction and Embryology.
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MAIN RESULTS AND THE ROLE OF CHANCE: Blastocysts formed by IVF developed at a slower rate and comprised fewer
cells that in-vivo generated blastocysts without culture (P< 0.05). Postnatal growth rate was increased in all four experimental treatments
compared with NM group (P< 0.05). SBP, serum and lung ACE and heart/body weight were higher in IVF-ET-BL versus IVF-ET-2Cell
males (P< 0.05) and higher than in other treatment groups, with SBP and lung ACE positively correlated (P< 0.05). Glucose handling
(GTT AUC) was poorer and basal insulin levels were higher in IVF-ET-2Cell males than in IVF-ET-BL (P< 0.05) with the glucose:insulin
ratio more negatively correlated with body weight in IVF-ET-2Cell males than in other groups. Liver/body weight and liver lipid droplet
diameter and density in IVF-ET-2Cell males were higher than in IVF-ET-BL males (P< 0.05). IVF groups had poorer health characteristics
than their in-vivo control groups, indicating that outcomes were not caused specifically by background techniques (superovulation, ET).
No consistent health effects from duration of culture were identified in female offspring.
LARGE SCALE DATA:N/A.
LIMITATIONS, REASONS FOR CAUTION: Results from experimental animal models cannot be extrapolated to humans.
Nevertheless, they are valuable to develop conceptual models, in this case, in the absence of confounding parental infertility, in assessing
the safety of ART manipulations.
WIDER IMPLICATIONS OF THE FINDINGS: The study indicates that longer duration of embryo culture after IVF up to blastocyst
before ET leads to increased dysfunction of CV health in males compared with IVF and shorter cleavage-stage ET. However, the metabolic
health of male offspring was poorer after shorter versus longer culture duration. This distinction indicates that the origin of CV and
metabolic health phenotypes after ART may be different. The poorer metabolic health of males after cleavage-stage ET coincides with
embryonic genome activation occurring at the time of ET.
STUDY FUNDING/COMPETING INTEREST(S): This work was supported through the European Union FP7-CP-FP Epihealth pro-
gramme (278418) and FP7-PEOPLE-2012-ITN EpiHealthNet programme (317146) to T.P.F., the Biotechnology and Biological Sciences
Research Council (BBSRC) (BB/F007450/1) to T.P.F., and the Saudi government, University of Jeddah and King Abdulaziz University to
A.A. The authors have no conflicts of interest to declare.
Key words: ART / mouse IVF and embryo culture / embryo transfer / blastocyst / DOHaD / offspring long-term health / growth
trajectory / CV health / metabolic health / liver phenotype
Introduction
Infertility is thought to affect an estimated 186 million people glob-
ally (Inhorn and Patrizio, 2015). The development of ART has pro-
vided a partial clinical resolution to infertility with over 8 million
children born to date, representing some 2–6% births in developed
countries (Berntsen et al., 2019; Crawford and Ledger, 2019).
Although most IVF children appear healthy according to numerous
systematic reviews, ART has been linked with a small increased risk
of adverse obstetric and perinatal outcomes and birth defects com-
pared with naturally conceived children (Pinborg et al., 2013; Qin
et al., 2017; Berntsen et al., 2019). In addition, longer-term health
concerns of ART offspring have been associated mainly with: altered
birthweight and growth (Ceelen et al., 2009; Kleijkers et al., 2014,
2016); increased risk of cardiovascular (CV) dysfunction comprising
CV remodelling during pregnancy with vascular impairment and
raised blood pressure evident in children through to at least adoles-
cence (Ceelen et al., 2008, 2009; Sakka et al., 2010; Scherrer et al.,
2012; Valenzuela-Alcaraz et al., 2013; Zhou et al., 2014; von Arx
et al., 2015; Guo et al., 2017; Meister et al., 2018); and susceptibility
to metabolic dysfunction including poorer glucose handling, insulin
resistance and increased triglycerides (Sakka et al., 2010; Chen
et al., 2014; Gkourogianni et al., 2014; Pontesilli et al., 2015; Guo
et al., 2017). In a minority of studies, impairment to neurological
and cognitive health have also been reported (Sandin et al., 2013;
Liu et al., 2017; Goldsmith et al., 2018).
These sustained health effects have been linked to the
‘Developmental Origins of Health and Disease’ (DOHaD) concept
suggesting environmental factors during development, especially the
peri-conceptional period, may alter subsequent growth and morpho-
genesis through epigenetic, cellular and physiological processes
(Feuer and Rinaudo, 2016; Fleming et al., 2018). However, evaluation
of ART children’s health is complex and confounded by the actual
technologies and precise protocols applied in clinics, the gradual re-
finement in practice over time, and appropriateness of controls and
comparator groups to distinguish between consequences mediated
through parental infertility and ART practice (Berntsen et al., 2019).
With these considerations in mind, animal models have been invalu-
able to assess effects of ART-associated technologies on long-term off-
spring health, removing confounders such as parental infertility and
treatment variability and including suitable controls. These indicate
ART treatments do indeed affect long-term health. Thus, IVF and/or
mouse embryo culture and transfer result in offspring with altered
growth trajectory, CV abnormalities and glucose/insulin dysfunction
(Watkins et al., 2007; Scott et al., 2010; Le et al., 2013; Rexhaj et al.,
2013; Chen et al., 2014; Donjacour et al., 2014; Feuer et al., 2014;
Ramirez-Perez et al., 2014; Schenewerk et al., 2014; Cerny et al.,
2017; Wang et al., 2018).
In the last decade, there has been a gradual switch in ART practice
from cleavage-stage embryo transfer (ET) to blastocyst stage ET to fa-
cilitate embryo selection and improve synchronicity with the uterine
environment, despite the potential risk of increased embryo environ-
mental perturbation. Whilst fresh blastocyst ET may marginally im-
prove the live birth rate (Glujovsky et al., 2016) without significantly
affecting birthweight (De Vos et al., 2018) or the risk of adverse
perinatal outcomes (Shi et al., 2019), it is unknown whether extended
culture negatively impacts on later health status. In the current study,
we have used a mouse model to assess the effect of cleavage or
2 Aljahdali et al.
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blastocyst ET on offspring health across a range of growth, CV and
metabolic criteria.
Materials and methods
Animals
Animal treatments were conducted in accordance with the UK Home
Office Animal (Scientific procedure) Act 1986 and local ethics commit-
tee at the University of Southampton. CBA male and C57/BL6 female
mice (source of embryos) and MF1 females (pseudo-pregnant recipi-
ents) were bred in-house (University of Southampton, Biomedical
Research Facility) on a 07:00–19:00 light cycle, 24C and fed ad libitum
from weaning on a standard chow diet (Special Diet Service, Ltd,
Witham, Essex, UK) and water.
Embryo production and treatment
Virgin female C57/BL6 mice (3–4 weeks old) were superovulated by
i.p. injection of 5 IU pregnant mare’s serum gonadotropin (PMSG,
Intervet, Cambridge, UK) and 46 h later, 5 IU hCG (Intervet,
Cambridge, UK). For in-vivo produced embryos, females were housed
overnight with CBA males. Plug positive females at embryonic day
0.5 (E0.5) (i.e. midday of plug detection day) were housed individually
and, at E1.5 and E3.5, females were killed by cervical dislocation and
two-cell embryos and blastocysts were flushed from dissected oviducts
and uteri, respectively, into pre-warmed H6 medium supplemented
with 4 mg/ml bovine serum albumin (BSA, A3311, Sigma, UK) (Nasr-
Esfahani et al., 1990). Some females were also naturally mated without
superovulation.
For IVF embryo production, sperm was retrieved from the cauda
epididymis of CBA males (8 weeks old) and placed into 90 ml sperm
pre-incubation medium TYH-MBCD (Takeo and Nakagata, 2011)
made in-house and equilibrated for 1 h at 37C in 5% CO2 in air.
C57/BL6 females were superovulated as above and cumulus masses,
collected from the oviduct ampulla 13 h post-hCG injection, were
placed directly into 200 ml fertilisation drop containing human tubal
fluid (HTF) medium made in-house with 1.0 mM reduced glutathione
(GSH, Sigma: G4251). Sperm (3-5 ml from pre-equilibrated TYH-
MBCD drop) were added to the fertilisation drop and incubated for
3–4 h to allow fertilisation to occur (Ishizuka et al., 2013). Presumptive
zygotes were washed through four drops HTF medium without GSH
and then cultured in the fourth drop under oil at 37C and 5% CO2 in
air to the next day (E1.5) before calculating the fertilisation rate. IVF
embryos (two-cell stage) were then divided into two groups, the first
was washed in pre-warmed M2 medium (Sigma; Cat No. M7167)
before transfer to E0.5 MF1 pseudo-pregnant mothers. The second
group was cultured in potassium simplex optimised medium with
amino acids and BSA (synthetic oviductal medium enriched with
potassium; Sigma-Aldrich) (Biggers et al., 2005) at 37C in 5% CO2 in
air to the blastocyst stage before washing in M2 medium and transfer
to E2.5 MF1 pseudo-pregnant mothers.
In-vivo and IVF-generated blastocyst trophectoderm (TE) and inner
cell mass (ICM) cell numbers were determined by differential nuclear
staining as described (Handyside and Hunter, 1984) with modifications
(Velazquez et al., 2018).
Embryo transfer
ET was performed by flank laparotomy in pseudo-pregnant MF1 recipi-
ents (7–8.5 weeks) obtained by mating with vasectomised MF1 males.
Two-cell embryos and blastocysts were washed three times in M2
medium prior to ET into the oviduct and uteri, respectively, in minimal
medium, as previously described (Velazquez et al., 2018). Recipients
were anaesthetised by a single intraperitoneal injection of Ketamine
(50 mg/kg, Ketaset, Pfizer, UK) and Xylazine (10 mg/kg, Rompun,
Bayer, UK). Embryos were transferred (19.7§ 6.05 per recipient) in
equal numbers into both maternal tracts with separate recipients used
for different treatments, as below. After transfer, exposed tracts were
placed back into the abdominal cavity, the peritoneum was sutured,
and the skin was closed with wound clips. Recipients were then kept
individually in a clean cage in a warm room (28–30C) to recover
from anaesthesia. Females were then housed in a quiet room for the
rest of their pregnancy and lactation. Litter size was adjusted to up to
8 per dam at birth with similar numbers of males and females.
Animal treatment groups
Eight to 13 litters were generated from each of five treatments with
groups termed as follows: (i) natural mating (NM)—naturally mated,
non-superovulated and undisturbed gestation; (ii) IV-ET-2Cell—in-vivo
derived two-cell embryos collected from superovulated mothers, with
immediate ET to recipients; (iii) IVF-ET-2Cell—IVF generated embryos
with oocytes from superovulated mothers cultured to the two-cell
stage before ET to recipients; (iv) IV-ET-BL—in vivo derived blastocysts
collected from superovulated mothers, with immediate ET to recipi-
ents; (v) IVF-ET-BL—IVF generated embryos with oocytes from
superovulated mothers cultured to the blastocyst stage before ET to
recipients. These treatment groups are shown in Fig. 1.
Offspring analysis
All offspring from the five treatment groups were weaned at 3 weeks
and males and females were caged separately per litter. Offspring
body weight was recorded weekly for 27 weeks. Systolic blood pres-
sure (SBP) was measured at postnatal weeks 9, 15 and 21 by tail-cuff
plethysmography with Non-Invasive Blood Pressure Monitor (NIBP-8,
Columbus Instruments, Columbus, OH, USA) in a pre-warmed room
(28–30C) to which mice were acclimatised for 90 min, as described
previously (Velazquez et al., 2018). Five SBP readings with good wave-
forms and good overall quality were taken per mouse, and the mean
value of the three middle readings was calculated and recorded. Heart
rate was monitored as an indicator of stress, and if reaching >500
beats per minute, SPB readings were delayed until heart rate reduced.
Glucose tolerance tests (GTT) were conducted at postnatal week 27
in unrestrained conscious mice after 15 h overnight fast, with access to
water. A standard protocol for GTT using a blood glucose meter
(Accu-Chek Aviva, Roche Diagnostics GmbH, Germany) to measure
blood glucose in small drops collected by tail tipping was employed.
Topical anaesthetic cream (Lidocaine 5%, Teva, UK) was applied to
the tail 20 min before starting the GTT. After recording of fasting glu-
cose level (0 min), a glucose (G8270, Sigma) solution (20%, in sterile
distilled water) was i.p. injected at a dose of 2 g/kg. Blood glucose lev-
els were measured at 15, 30, 60 and 120 min after glucose administra-
tion. Area under the curve (AUC) values were calculated by the
Mouse embryo culture duration and long-term health 3
D
ow
nloaded from
 https://academ
ic.oup.com
/hum
rep/advance-article/doi/10.1093/hum
rep/deaa205/5918113 by guest on 19 O
ctober 2020
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..trapezoidal rule (Matthews et al., 1990). Organ Allometry was deter-
mined 2 days after GTT: mice were sacrificed by cervical dislocation,
blood was collected by heart puncture and organs (i.e. liver, heart, left
and right kidneys, lung and spleen) were weighed, snap frozen in liquid
nitrogen and stored at 80C. Blood samples were centrifuged at
4C for serum collection and stored at 80C.
Angiotensin-converting enzyme activity
The method was used as previously (Watkins et al., 2006, 2007) to
measure serum and lung angiotensin-converting enzyme (ACE) activi-
ties, the classical enzyme regulator of the renin-angiotensin system
converting Angiotensin I to the vasopressor Angiotensin II (Li et al.,
2017). The assay is based on the colourimetric determination of hip-
purate with cyanuric chloride/dioxan reagent. Briefly, for serum ACE
activity, samples were incubated in hippuryl-L-histidyl-L-leucine (HHL;
Sigma) solution in H3PO3 buffer at 37C, the reaction was terminated
with HCl (Sigma) followed by addition of cyanuric chloride (Sigma) in
1,4-dioxan (Sigma) for yellow colouration to develop. Four replicates
per sample were analysed using a plate reader (Varioskan Flash
Multimode Reader; Thermo Scientific) at 380 nm. Negative controls
comprised addition of HCl before HHL. A Hippurate standard curve
(20–100 mM) was prepared from 112 mg Hippuric acid (Sigma) solu-
tion in 250 ml 20 mmol/l NaOH, treated as samples except the addi-
tion of HHL. Each of the four replicates per sample were analysed in
duplicate, and the average of these eight readings taken. For lung ACE
activity, lung samples of 50 § 1 mg were homogenised in 300 ll ice-
cold boric buffer (H3BO3, 2M NaCl, pH 8.3; Sigma) with a PowerGen
homogeniser, centrifuged at 16 400 rpm for 10 min at 4C and the su-
pernatant was removed and stored at 80C. Pellets were homoge-
nised in 300 ll buffer and centrifuged, and the supernatant was
removed and stored. Duplicate analysis of four replicate supernatants
per sample was analysed as described for serum ACE activity. Total
protein content of samples was measured using a BioRad kit. Serum
ACE activity was expressed as amount (in mM) of hippurate formed
per millilitre of serum per minute; lung ACE activity was expressed as
amount (in nanomolar) of hippurate formed per milligram of protein
per minute. Serum and lung samples were selected at 27 weeks from
the same offspring at the middle weight across litters from the five
treatment groups (one male and one female from each of 7–9 moth-
ers per treatment) and stored frozen. These same offspring were used
for serum glucose and insulin assays and for the liver lipid metabolism
assay.
Serum glucose and insulin analysis
Glucose concentration in offspring serum was measured using the gluc-
ometer as described in the GTT procedure. Serum insulin concentra-
tion was determined using an ELISA kit (Mercodia, Sweden, Mouse:
10-1247-01) based on the manufacturer’s instructions. Briefly, 10 ml of
each calibrator 0, 1, 2, 3, 4 and 5 and serum samples were incubated
in coated microplate wells with 100 ml enzyme conjugate solution on a
plate shaker at room temperature at 750 rpm for 2 h, before washing
in 350 ml of wash buffer repeated five times, before addition of 200 ml
TMB substrate and incubation for 15 min, before addition of 50 ml
stop solution. Absorbance was measured at 450 nm using a Varioskan
Flash Multimode Reader (Thermo Scientific). Standard deviation and
coefficient of variance were calculated for each sample run in duplicate
in three plates and mean insulin values were calculated. The glucose/
insulin ratio (G:I) ratio was calculated to assess insulin resistance
(McAuley et al., 2001). A total of 6–8 samples from each treatment,
both male and female and each from a separate mother, were used
for combined glucose and insulin analyses.
Figure 1. Experimental design showing the five treatment groups used.
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.Liver morphometrics and metabolism
Frozen-stored adult offspring median lobe liver samples were embed-
ded in OCT-compound and cryosections at 7 mm were generated and
stained with Oil Red O to visualise lipid accumulation and Mayer’s
Haematoxylin as counterstain before mounting in aqueous medium
and applying coverslips. Images of sections were analysed and photo-
graphed using an Olympus dotSlide Virtual Microscopy System with an
Olympus BX61 Microscope Frame at 10 magnification. Images
(3 per liver sample) were quantified using Fiji software for red-stained
lipid accumulation with the Watershed tool applied to separate
grouped lipid droplets. A total of 6–9 offspring from each treatment,
both male and female and each from a separate mother, were used
for liver analyses.
Statistics
Statistical analyses were performed with the IBM SPSS Statistics soft-
ware, version 21 (IBM Corporation) and significance was taken as
P 0.05. If a P-value of between 0.1 and 0.05 was observed, a trend
was assumed to exist. Blastocyst cell number, rates of blastocyst de-
velopment and ET outcome (i.e. pregnancy rate, ET efficiency and lit-
ter size) were analysed using a one-way ANOVA followed by a
pairwise t-test with Bonferroni correction analysis. Percentage data
were arcsine transformed before ANOVA analysis. Postnatal data,
comprising offspring weights, SBP, GTT, organ weights and ratios,
post-culling serum glucose and insulin, serum and lung ACE activities
and liver lipid accumulation data, were analysed using multilevel ran-
dom effects regression models to compare treatment groups (Kwong
et al., 2004) and to analyse relationships between different readouts
(i.e. correlations) within each treatment group (Velazquez et al., 2018).
All postnatal data were converted to Z-scores before being analysed
with the regression models which took into account between-mother
and within-mother variation and litter size (Kwong et al., 2004;
Watkins et al., 2008).
Results
IVF and embryo culture delay blastocyst
development and reduce cell proliferation
Routine analysis of IVF embryo development was conducted through-
out the study, with oocytes (n¼ 1720) collected from 40 superovu-
lated dams, used in 14 separate IVF experiments, leading to an overall
mean success rate of two-cell embryo formation of 92%, and from
those allocated to culture, 81% formed morulae and 72% developed
to blastocysts. The developmental rate of IVF embryos was compared
with in-vivo embryos (superovulated; naturally mated; develop in vivo;
collected at E3.5). IVF embryos developed more slowly and only
reached the morula stage at E3.5 whilst in-vivo embryos had become
expanding blastocysts by then (Table I). IVF embryos became expand-
ing blastocysts by E4.5 (Fig. 2A and B; Table II). Some IVF and in-vivo
mid-expanded blastocysts at E4.5 and E3.5 days, respectively, were
subjected to differential cell staining which showed increased TE, ICM
and total cell numbers in in-vivo versus IVF embryos (P< 0.05) al-
though the ICM:TE ratio did not differ between the two groups
(Fig. 2C and D). IVF and prolonged culture therefore delayed
blastocyst formation and reduced associated proliferation of both cell
lineages compared with in-vivo development.
Postnatal offspring from ART treatments
display increased body weight
To study the effect of ART and embryo culture duration on postna-
tal development, we generated the five treatment groups as shown
in Fig. 1 with the offspring production criteria shown in Table II. The
ET pregnancy rate (% dams giving birth) was significantly higher in
the IV-ET-BL group compared with IVF-ET-BL, otherwise no differ-
ences were found between groups (Table II). ET efficiency (pups
generated per numbers of embryos transferred) was lower in IVF-
ET-BL than other groups. Litter size in the ET groups IV-ET-2Cell,
IV-ET-BL and IVF-ET-BL was lower than the NM group. The IVF-
ET-BL litter size was also lower than the IVF-ET-2Cell group.
Male:female ratio was not different between any of the treatment
groups (Table II).
Male and female offspring body weight differences between groups
were analysed from weaning through to Week 27, taking into consid-
eration litter size and individual maternal origin. All four ET groups
were significantly heavier compared with the NM control group, evi-
dent from Week 5 (males) and 4 (females) through to Week 27
(Fig. 3A and C). Z-score plots confirmed increased body weight for all
ET groups compared with the NM group up to Week 27 (Fig. 3B and
D). Generally, weight differences between different ET groups were
minimal and are itemised in the Fig. 3 legend. Notably, IVF-ET-BL fe-
male mean weight was heavier than other ET groups throughout the
27-week period (Fig. 3C and D). Thus, the combined techniques of
ART (superovulation, IVF, culture, transfer, recipient gestation) in our
model, or just some of them (minimal superovulation, transfer, recipi-
ent gestation), resulted in sustained increase in postnatal weight in
both sexes compared with natural, unstimulated reproduction.
Male offspring from IVF and prolonged
culture before ET develop CV dysfunction
SBP was determined at 9, 15 and 21 weeks and the mean of these also
recorded as LIFE (Fig. 4). In males, mean SBP for all time points was
consistently highest in IVF-ET-BL, reduced in IVF-ET-2Cell, the two IV-
ET control groups and lowest in the NM group (Fig. 4A). IVF-ET-BL
male SBP was increased at Weeks 15, 21 and LIFE compared with IVF-
ET-2Cell (P¼ 0.032, 0.034 and 0.017, respectively) and with IV-ET-BL
(P¼ 0.003, 0.014 and 0.001, respectively) (Fig. 4A). In females, al-
though a similar SBP pattern existed across treatment groups, the dif-
ferences were not significant between ET groups (Fig. 4B). However,
NM females showed significant lower SBP than females in IV-ET and
IVF-ET groups at Weeks 15, 21 and LIFE (P< 0.05).
Serum and lung ACE activity, known to associate with increased
SBP (Li et al., 2017), were further measured in offspring. Male IVF-ET-
BL offspring recorded the highest serum and lung ACE activity, both
being higher (P< 0.05) than in the IVF-ET-2Cell males (Fig. 4C and D).
IVF-ET-BL lung ACE in males was also higher than the control IV-ET-
BL males (P< 0.05) (Fig. 4D). However, ACE activities were not dif-
ferent across groups in female offspring (Fig. 4C and D). Correlation
analysis of SBP and ACE activity revealed a significant positive correla-
tion between both SBP 21 weeks and SBP LIFE with Lung ACE activity
Mouse embryo culture duration and long-term health 5
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in male IVF-ET-BL offspring but not in females nor in any other treat-
ment group (Table III).
The combined techniques of ART (superovulation, IVF, culture, ET,
recipient gestation) therefore contribute to adverse postnatal CV
health compared with natural unstimulated reproduction but with pro-
longed versus short embryo culture exacerbating these effects in male
offspring.
Male offspring from IVF and short culture
before ET develop impaired glucose and
insulin metabolism
Glucose metabolism of offspring was assessed by glucose tolerance
test (GTT) at postnatal Week 27. Male offspring fasting glucose level
(i.e. 0 min) and after 15, 30 min, 1 and 2 hr of i.p glucose injection
showed all treatment groups to have significantly slower recoveries
and larger AUC than the NM control group (Fig. 5A and B). Glucose
recovery and AUC for IVF-ET-2Cell was poorer compared with both
IV-ET-2Cell (P¼ 0.05–0.004) and IVF-ET-BL males (P¼ 0.03–0.003).
In female offspring, fasting glucose level, glucose recovery and AUC
also appeared to be poorer in treatment groups compared with the
NM control although the differences were not always significant. No
significant differences were detected between the four treatment
groups in females (Fig. 5C and D).
Serum samples collected at 27 weeks during animal culling were
used to measure insulin and glucose levels and the glucose:insulin ratio
(G:I), a measure of insulin effectiveness in glucose homeostasis. In
male offspring, glucose levels were similar across treatments with IV-
ET-BL higher than IV-ET-2Cell and NM (P< 0.05; Fig. 6A). In contrast,
insulin levels differed substantially across treatments with IVF-ET-2Cell
males being significantly higher than all other groups (P< 0.05; Fig. 6B).
The lowest insulin level was in NM males which led to the highest G:I
ratio in NM males and this was significantly higher than in IV-ET-2Cell,
IVF-ET-2Cell and IV-ET-BL groups (P¼ 0.005, P¼ 0.001 and
P¼ 0.038, respectively; Fig. 6C). Female serum glucose was unchanged
across treatments (Fig. 6A) while insulin was lowest in the NM group
and significantly raised in IVF-ET-2Cell females (P< 0.05; Fig. 6B),
resulting in G:I ratio highest in NM females, as in males, and signifi-
cantly higher than in IV-ET-BL and IVF-ET-2Cell females (P< 0.05;
Fig. 6C).
Metabolic outcomes were analysed for possible associations with
other phenotypes; the G:I ratio in particular was found to be signifi-
cantly negatively correlated both with body weight throughout postna-
tal life and with AUC from the GTT in the IVF-ET-2Cell male but not
female offspring (Table III). Other groups with ET treatment also
showed weaker associations between these parameters but there
were no associations on the NM group (Table III).
The combined techniques of ART (superovulation, IVF, culture, ET,
recipient gestation) therefore contribute to adverse postnatal meta-
bolic health as measured by glucose homeostasis compared with natu-
ral unstimulated reproduction. Here, evidence of insulin resistance was
most pronounced after short embryo culture particularly in male
offspring.
Offspring from IVF and short culture
before ET develop increased lipid
accumulation in liver
Metabolic health of offspring was also assessed by analysis of lipid ac-
cumulation in liver cryosections stained with Oil Red O using organs
stored at 27 weeks at culling. Representative images of lipid accumula-
tion in male liver sections are shown in Fig. 7A. Lipid droplet size was
increased in IVF-ET-2Cell offspring relative to other groups and espe-
cially in males. IVF-ET-2Cell lipid size was increased compared with
IVF-ET-BL (P¼ 0.015) and with IV-ET-2Cell (P¼ 0.015) in males
(Fig. 7B). Moreover, the relative percentage area of lipid accumulation
was increased in IVF-ET-2Cell versus IVF-ET-BL at trend level
(t¼ 0.065) and versus control IV-ET-2Cell (P¼ 0.003) in males
(Fig. 7C). Thus, IVF and transfer after short rather than long culture
contribute to adverse liver lipid accumulation as well as impaired
glucose-insulin metabolism, especially in males.
............................................................................................................................................................................................................................
Table I Developmental rate of in vivo and IVF embryos at E3.5 and E4.5.
Group Number (%)
Mean (SD § SEM) from each dam
Dam
number
Embryo
number
Morula Early
blastocyst
Mid
blastocyst
Late
blastocyst
Arrested
(early cleavage)
in vivo
22 469
15 (3.2) 40 (8.5) 114 (24.3) 295 (62.9) 5 (1.1)
E3.5 0.71 (0.72 § 0.15) 1.9 (0.89 § 0.19) 5.43 (1.29 § 0.27) 14.05 (3.31 § 0.7) 0.24 (0.44 § 0.09)
IVF
40 10761
876 (81.4) 0 0 0 200 (18.6)
E3.5 62.57 (38.14 § 6.03) 14.28 (5.69 § 0.9)
IVF 109 (12.4)2 51 (5.8)2 83 (9.5)2 633 (72.3)2 0
E4.5 7.78 (5.1 § 0.81) 3.64 (1.98 § 0.31) 5.92 (3.19 § 0.5) 45.21 (28.12 § 4.45)
Early blastocyst has a blastocoel volume less than half of the total embryo volume.
Mid blastocyst has a blastocoel volume equal to or larger than the total embryo volume.
Late blastocyst blastocoel fully expanded within the embryo whilst the zona pellucida (ZP) is thinning.
1Number of 2-cell embryos cultured after IVF.
2Per cent of morulae at E3.5.
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.Postnatal offspring from ART treatments
display altered organ allometry
Offspring were sacrificed at postnatal Week 27 and organ/body
weight ratios were determined before organ freeze storage. Male off-
spring organ weight was generally proportional to body weight but
with exceptions (see Fig. 8 for details). Notably, IVF-ET-2Cell
males had relatively smaller lungs, hearts and right kidneys and
larger livers compared with NM males, whilst IVF-ET-BL males
also had larger livers and spleens compared with NM males
(Fig. 8A). IVF-ET-BL males had larger hearts and smaller livers than
IVF-ET-2Cell males. The IV-ET-2Cell and IV-ET-BL control groups
had few organ size differences from NM males. In contrast, female
offspring from ART treatments generally had smaller proportioned
organ sizes, especially lungs and hearts, compared with NM
females but differences between the two IVF groups were not ap-
parent (Fig. 8B). The combined techniques of ART (superovula-
tion, IVF, culture, transfer) therefore contribute to altered organ
allometry in both male and female offspring compared with natural
unstimulated reproduction.
Discussion
We have used an animal model to address the safety for long-term
offspring health of specific ART techniques in common practice in clin-
ics and in the absence of confounding parental infertility. Given the
Figure 2. Effect of IVF and prolonged embryo culture on blastocyst development cell number. IVF embryos at E3.5 comprise moru-
lae (A) and at E4.5 comprise blastocysts (B); bar ¼ 100 mm. (C) IVF embryos (n¼ 50) have fewer cells than in-vivo embryos (n¼ 87) at the blastocyst
stage. Mean (§SEM) blastocyst cell number for IVF compared with in-vivo embryos (P< 0.05). (D) Mean (§SEM) ICM/TE ratio of blastocysts.
* P< 0.05.
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Table II Offspring production criteria for the five treatment groups as shown in Fig. 1.
Treatment
Group
ET pregnancy rate1 %
(dam numbers)
ET efficiency2 %
(pups/ embryos transferred)
Birth litter size3
Mean (SD § SEM)
[litter number]
Offspring
number
No. male/
female pups
Ratio
Male:Female
NM N/A N/A 8 (1.33 § 0.42)a [10] 80 40/40 1
IV-ET-2Cell 88.9 (8/9) 31.7 (57/180)a 7.12 (4.36 § 1.54)b [8] 57 32/25 1.3
IVF-ET-2Cell 73.3 (11/15) 16.7 (75/450)a 8.33 (3.74 § 1.25)a1 [9] 75 42/33 1.2
IV-ET-BL 81.8 (9/11)a 30.5 (47/154)a 5.88 (1.73 § 0.61)b [8] 47 22/25 0.9
IVF-ET-BL 48.3 (14/29)b 9.1 (42/464)b 3.23 (1.79 § 0.5)b,b1 [13] 42 26/16 1.6
Data were analysed using ANOVA (mean§ SEM).
1Dams that gave birth/total number of ETs performed.
2Total number of pups at birth (before litter size correction)/total embryos transferred (7–15 per side).
3Calculated on dams with live pups at birth (before litter size correction).
a,b; a1,b1Within a column, values with different letters are significantly different (P< 0.05).
Figure 3. Effect of ART techniques on growth of offspring. Body weight and Z-score analysis in male (A and B) and female (C and D) off-
spring. Multilevel random effects regression analysis. *Indicates a significant difference (P< 0.05) between NM and other treatments;

denotes NM
vs. (IV-ET-2Cell, IVF-ET-2Cell and IVF-ET-BL) at Week 3 and NM vs. IV-ET-BL at Week 4 (P 0.05), D indicates IV-ET-2-Cell vs. IV-ET-BL and
 indicates IVF-ET-BL vs. IVF-ET-2Cell (P 0.05). Mean (§SEM) body weight from 3 to 27 weeks (from 8 to 13 litters); n of mothers or foster
mothers $, n of offspring.
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past record of adverse offspring health risk mediated through embryo
culture (Cagnone and Sirard, 2016; Sunde et al., 2016; Fleming et al.,
2018), the model was designed to distinguish specifically between
short and long culture duration either up to cleavage-stage (two-cell)
or blastocyst transfer, respectively. Both groups (IVF-ET-2Cell; IVF-ET-
BL) were supported by direct in-vivo controls for transfer at these two
stages (IV-ET-2Cell; IV-ET-BL) which included the background ART
techniques (superovulation; ET) but in the absence of the tested tech-
niques (IVF; short or long culture). These four groups were also com-
pared with a NM group where no ART techniques were applied.
Thus, the model is suitable for direct comparison of the health conse-
quences for offspring arising from IVF and culture duration indepen-
dent of other techniques, but also permits evaluation of the
background techniques and the collective of all ART techniques.
However, our design required the use of atmospheric oxygen rather
than 5% for culture, although the former is reported to still be
practised in some 40% of IVF cycles worldwide (van Montfoort et al.,
2020). This choice was necessary to maintain consistency between the
two IVF groups and their two IV controls where embryo incubation
was kept to an absolute minimum, essentially the time to complete ET
in the surgery room, and could not be accomplished at 5% O2
for practicalities. Finally, the statistical approach of random effects
regression analysis on the dataset permits outcomes to be evaluated
in the entire offspring generated by each treatment rather than just on
litter means, thereby integrating variability both within- and between-
mothers and independent of the effect of litter size (Kwong et al.,
2004), as used in our previous periconceptional DOHaD models
(Watkins et al., 2008; Velazquez et al., 2016, 2018).
One enduring feature of the dataset was the distinction between
offspring phenotype arising from all four manipulated groups with that
of the NM group. Thus, compared with the NM group, offspring from
manipulated groups exhibited increased postnatal growth and poorer
Figure 4. Effect of ART techniques on cardiovascular function in offspring. Postnatal systolic blood pressure (SBP) at indicated weeks
of age and mean of these for individual offspring (LIFE), in male (A) and female (B) offspring; mean (§SEM) from 8 to 13 litters. Serum ACE activity
(C) and lung ACE activity (D) in male and female offspring; mean (§SEM) from 7 to 9 litters per treatment. Multilevel random effects regression
analysis. *Indicates a significant difference (P< 0.05) between NM and selected groups; ^ indicates IV-ET-BL vs. IVF-ET-BL, and  indicates IVF-ET-
BL vs. IVF-ET-2Cell differences (P< 0.05). n of mothers or foster mothers $, n of offspring. ACE, angiotensin-converting enzyme.
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.CV and metabolic health across the spectrum of assays undertaken,
commonly in both male and female offspring at significant levels. This
broad and unequivocal phenotypic consequence at one level demon-
strates the collective effect of the ART techniques applied over the
lifespan but is likely to be exaggerated because of the use of MF1
recipients for gestation and lactation. For example, it is established
that the maternal uterine genotype of mouse recipients can influence
offspring phenotype such as postnatal growth rate (Cowley et al.,
1989). Whilst we used inbred C57BL6/CBA embryos for genomic
stability and capacity to overcome the ‘2-cell block’ in culture, outbred
MF1 recipients were necessary to enhance pregnancy efficiency, a
combination we have used successfully previously for DOHaD-related
mouse studies (Velazquez et al., 2016). Thus, the growth rate of off-
spring from the manipulated groups here broadly matched that previ-
ously reported (Velazquez et al., 2016) and is similar to MF1 offspring
from natural pregnancies (Watkins et al., 2008) or slightly below that
following MF1 embryo manipulations and transfer to MF1 recipients
(Velazquez et al., 2018).
In the critical group comparison of culture duration after IVF with
all other ART techniques normalised, we found a curious dichotomy
between IVF-ET-2Cell and IVF-ET-BL offspring, and particular males,
in that CV outcomes (SBP; ACE activity; larger heart/body mass)
were poorer in IVF-ET-BL treatments but conversely, metabolic
outcomes (glucose response; raised basal insulin; increased liver/
body mass; increased liver lipid accumulation) were poorer in the
IVF-ET-2Cell group. Both CV phenotype in IVF-ET-BL and metabolic
phenotype in IVF-ET-2Cell males were poorer than their respective
controls (IV-ET-BL; IV-ET-2Cell) indicating outcomes were predomi-
nantly derived from IVF and culture duration, perhaps in combina-
tion with the timing of ET (discussed later), rather than by in-vitro
manipulations and ET per se. To assess the basis for this dichotomy
in health outcomes in IVF-ET-BL and IVF-ET-2Cell offspring, we first
need to consider the direct effects of in-vitro culture on the early
embryo.
Our study showed that in-vitro culture, although permissive for blas-
tocyst formation, was suboptimal, slowing development and reducing
proliferation of TE and ICM cells, as previously reported in other
mouse ART models (Watkins et al., 2007; Chen et al., 2019). Culture
conditions can interfere with two critical aspects of preimplantation
development, namely embryo metabolism and the epigenetic regula-
tion of the new embryonic genome. Embryo metabolism matures pro-
gressively from a low rate during fertilisation and early cleavage,
dependent upon mitochondrial oxidative phosphorylation for energy
production, and increases substantially at the blastocyst stage
(Houghton et al., 1996; Leese, 2012). This progression is accompanied
by upregulated glycolysis in late cleavage stages, further enhancing en-
ergy availability for blastocyst morphogenesis, especially epithelial
transport activity and increased protein synthesis for growth
(Houghton et al., 1996; Leese, 2012). Mitochondrial morphology also
matures during cleavage with normal transverse cristae formation coin-
ciding with the increased efficiency of ATP production at morula and
blastocyst stages (Harvey, 2019). The unnatural metabolite milieu ex-
perienced in embryo culture can induce oxidative stress through in-
creased production of reactive oxygen species alongside ATP in the
mitochondrial electron transport chain (Takahashi, 2012; Cagnone and
Sirard, 2016). Whilst natural protective mechanisms exist through anti-
oxidant enzymes to maintain the redox balance, culture conditions can
perturb this balance leading to impaired development affecting growth,
gene expression and survival (Leese, 2012; Takahashi, 2012; Cagnone
and Sirard, 2016). Indeed, direct manipulation of energy substrates,
............................................................................................................................................................................................................................
Table III Phenotypic correlations betweendifferent offspring outcomes across treatments.
Natural mating IV-ET-2cell IV-ET-BL IVF-ET-2cell IVF-ET-BL
Male
(n5 8)
Female
(n5 8)
Male
(n5 6–8)
Female
(n5 7–8)
Male
(n5 6–8)
Female
(n5 6–7)
Male
(n5 8–9)
Female
(n57–9)
Male
(n5 7–9)
Female
(n57–9)
Cardiovascular phenotype
SBP wk21  Lung ACE 0.190 0.415 0.556 0.370 0.184 0.130 0.026 0.223 0.902* 0.119
SBP LIFE  Lung ACE 0.118 0.107 0.415 0.353 0.693$ 0.328 0.101 0.195 0.714* 0.177
G:I and body weight
G:I ratio  BW3 0.305 0.351 0.211 0.566 0.403 0.080 0.224 0.160 0.676$ 0.268
G:I ratio  BW9 0.111 0.169 0.621 0.649 0.936* 0.789$ 0.806* 0.073 0.664 0.013
G:I ratio  BW15 0.128 0.303 0.761$ 0.735$ 0.904* 0.749$ 0.807* 0.309 0.700$ 0.053
G:I ratio  BW21 0.287 0.184 0.848* 0.710$ 0.871* 0.664 0.812* 0.008 0.748$ 0.122
G:I ratio  BW27 0.001 0.448 0.832* 0.883* 0.768$ 0.910* 0.935* 0.026 0.806* 0.741$
G:I ratio  FG 0.523 0.183 0.040 0.431 0.651 0.471 0.640$ 0.090 0.437 0.198
G:I ratio  GTT 15 min 0.010 0.021 0.082 0.282 0.383 0.679 0.806* 0.137 0.767* 0.234
G:I ratio  GTT 120 min 0.298 0.350 0.753$ 0.547 0.432 0.927* 0.648$ 0.043 0.707$ 0.201
Insulin – AUC 0.023 0.111 0.013 0.208 0.252 0.912* 0.860* 0.315 0.659 0.420
G:I ratio  AUC 0.195 0.107 0.263 0.371 0.540 0.960* 0.862* 0.116 0.819* 0.530
SBP LIFE, average (SBP9, SBP15 and SBP21); ACE, angiotensin-converting enzyme; G:I G:I ratio, Serum glucose: Serum insulin ratio; BW, body weight as specific week; AUC, area un-
der the curve for GTT test; Insulin, Serum insulin; FG, fasting glucose.
$P< 0.1; *P< 0.05.
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..mitochondrial activity and redox potential in mouse zygotes leads to
altered postnatal growth rates (Banrezes et al., 2011). Furthermore, a
range of environmental factors including maternal over-nutrition and
obesity have also been shown to disturb mitochondrial functioning,
localisation and mtDNA copy number in oocytes and early cleavage
embryos with enduring effects on foetal and postnatal growth and me-
tabolism (Igosheva et al., 2010; Grindler and Moley, 2013; Wu et al.,
2015).
The second consequence of adverse culture environment is to inter-
fere with the epigenetic reprogramming of the new embryonic genome
(Chason et al., 2011; Cagnone and Sirard, 2016; Sunde et al., 2016).
Global demethylation of the genome during cleavage is followed by a
gradual, lineage-specific pattern of de-novo methylation initiated in the
blastocyst to coordinate development (Seisenberger et al., 2013).
Thus, culture environment may alter the expression and methylation
level of imprinted genes within the embryo persisting into later
developmental stages (Doherty et al., 2000; de Waal et al., 2014).
Non-imprinted genes are also vulnerable to culture conditions with
the global pattern of gene expression (Feuer et al., 2017) and DNA
methylation distinct from that of in-vivo embryos (Wright et al., 2011;
Salilew-Wondim et al., 2015; Canovas et al., 2017). Epigenetic distur-
bance may at least partially derive from mitochondrial dysfunction
since mitochondria supply intermediates in DNA methylation and his-
tone acetylation through the 1-carbon metabolism pathway (Xu and
Sinclair, 2015; Cagnone and Sirard, 2016; Ducker and Rabinowitz,
2017).
Figure 5. Effect of ART techniques on glucose metabolism in offspring. Intraperitoneal GTT at 0, 15, 30, 60 and 120 min and AUC in
male (A and B) and female (C and D) offspring; mean (§SEM) in 8–13 litters per treatment. Multilevel random effects regression analysis. *Indicates
a significant difference (P< 0.05) between NM and selected groups; D indicates IV-ET-2-Cell vs. IV-ET-BL, # indicates IV-ET-2Cell vs. IVF-ET-2Cell,
and  indicates IVF-ET-BL vs. IVF-ET-2Cell differences (P 0.05). n of mothers or foster mothers $, n of offspring.
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The poorer CV outcomes identified in IVF-ET-BL males after long
culture versus both control IV-ET-BL and short culture IVF-ET-2Cell
groups likely reflects the progressive negative effects of in-vitro culture
on embryo metabolism and epigenetic stability. Indeed, we show a
progressive increase in SBP in male offspring based upon the duration
of culture from IV controls through to IVF-ET-BL offspring. Cardiac
and associated vasculature form very early during development, from
E8.5 in mouse, and is a complex morphogenetic process essential for
embryo survival with recent research identifying significant epigenetic
regulation (Kathiriya et al., 2015). Adult CV dysfunction occurs in re-
sponse to a wide range of peri-conceptional environments, indicating
its sensitivity (Fleming et al., 2018). Moreover, an epigenetic basis for
adverse CV health including arterial hypertension has been reported in
a mouse ART model, mediated through altered DNA methylation of
the endothelial eNOS gene in the aorta, leading to reduced eNOS ex-
pression and disturbed NO signalling (Rexhaj et al., 2013). Notably,
the CV phenotype and associated epigenetic alteration in the eNOS
gene can be prevented by inclusion of the epigenetic regulator, mela-
tonin, in embryo culture medium (Rexhaj et al., 2015). Indeed, the sig-
nificant positive correlation identified between SBP and lung ACE level
in the IVF-ET-BL males, but not other groups, suggests that ACE ex-
pression, known to be epigenetically regulated (Mudersbach et al.,
2019) and sensitive to the peri-conceptional environment (Watkins
et al., 2006, 2007), may contribute an epigenetic pathway to affect
later CV health.
In contrast to the clear link between extended culture and off-
spring CV dysfunction, it was the IVF-ET-2Cell group with shorter
culture duration that lead to the poorer metabolic phenotype in off-
spring. Collectively, male offspring from this treatment demon-
strated poorer glucose handling which correlated negatively with
body mass, increased basal insulin levels, increased relative liver siz-
ing and liver lipid accumulation, compared with either the direct
control group (IV-ET-2Cell) or the IVF-ET-BL group. Increased birth
weight and poorer glucose and insulin regulation were previously
reported in mouse IVF offspring following ET at the two-cell stage
but predominantly in females (Scott et al., 2010). Similar poorer glu-
cose handling mainly in female offspring following IVF was found af-
ter mouse blastocyst ET and coincided with metabolic dysfunction
across several tissues including liver, evidenced by microarray analy-
sis (Feuer et al., 2014). Furthermore, liver metabolic dysfunction in-
cluding accumulation of monounsaturated fatty acids has been
reported following mouse IVF and ET at the two-cell stage (Wang
et al., 2013). Mouse IVF also leads to increased phospholipid accu-
mulation in foetal liver (Li et al., 2016), indicating prenatal origin of
ART-mediated metabolic impairment. Given the increased accumu-
lation of lipid in the male IVF-ET-2Cell liver, it would be interesting
in future studies to determine serum lipid levels and adipose tissue
composition for a broader understanding of lipid dysregulation in
this group. The co-occurrence of markers of metabolic disease risk
in several studies, as well as in our current study, confirm the link
between ART and adult metabolic health.
This distinction in outcomes between IVF-ET-2Cell and IVF-ET-BL
groups suggests different mechanisms and biological pathways may
be at work for metabolic and CV outcomes. Apart from the shorter
culture duration, the IVF-ET-2Cell group experienced ET during the
two-cell stage when the mouse embryonic genome is predominantly
activated (EGA) (Flach et al., 1982). The period of EGA at
the transition from maternal to embryonic control of development
is recognised as one of particular sensitivity to culture conditions
across mammalian species, affecting embryo potential
Figure 6. Effect of ART techniques on glucose and insulin
levels in offspring. Serum glucose (A), serum insulin (B) and
G:I ratio (C) in male and female offspring; mean (§SEM) from 6 to 8 lit-
ters per treatment. Multilevel random effects regression analysis.
*Indicates a significant difference (P< 0.05) between NM and
selected groups; D indicates IV-ET-2-Cell vs. IV-ET-BL, # indicates IV-
ET-2Cell vs. IVF-ET-2Cell, and  indicates IVF-ET-BL vs. IVF-ET-2Cell
differences (P 0.05). n of mothers or foster mothers $, n of offspring.
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..(Lonergan et al., 2003; Zander et al., 2006) and is discussed in detail
elsewhere (Brison et al., 2014). A convincing argument suggests that
stressful manipulations during the EGA (such as ET here) may be ac-
centuated by the absence of gap junction communication between
blastomeres to coordinate homogeneity and protection in intercellu-
lar maturation (Brison et al., 2014). EGA in the human occurs
slightly later in cleavage, at the 4- to 8-cell transition (Braude et al.,
1988; Vassena et al., 2011), but cleavage ET in human ART normally
coincides with this cellular stage.
A further characteristic of our study has been the clear disparity in
outcomes based upon offspring sex with males being far more sensi-
tive that females. Sexual dimorphism has been commonly found in
periconceptional DOHaD programming studies in response to diverse
challenges including ART-based models and evident in small and large
mammals and humans (Hansen et al., 2016; Fleming et al., 2018). In
mouse studies of embryo culture effects on offspring cardiometabolic
health, males commonly show increased sensitivity, as here
(Donjacour et al., 2014; Velazquez et al., 2018), but female vulnerabil-
ity has been shown elsewhere (Feuer et al., 2014), indicating that strain
differences may be contributory. This also likely reflects different sus-
ceptibilities to CV disease based on sex, which arise in utero
(Schalekamp-Timmermans et al., 2016). Environmental conditions such
as nutrient and metabolite levels both in vivo and in vitro can differen-
tially influence embryo response in terms of signalling activity, gene
Figure 7. Effect of ART techniques on lipid accumulation in offspring liver. Representative images of liver cryosections from male
offspring stained with Oil Red O from each treatment group (A). Average lipid droplet diameter (B) and percentage lipid-stained area (C) in male
and female offspring; mean (§SEM) from 6 to 9 litters per treatment. *Indicates a significant difference (P< 0.05) between NM and selected groups;
 indicates IVF-ET-BL vs. IVF-ET-2Cell (B, P¼ 0.015; C, t¼ 0.065), and # indicates IV-ET-2Cell vs. IVF-ET-2Cell differences (P< 0.05). n of mothers
or foster mothers $, n of offspring.
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expression and morphogenesis in a sex-specific manner that can per-
sist through gestation and postnatal life (Hansen et al., 2016).
Conclusion
We have shown that IVF and embryo culture in a mouse model spe-
cifically associate with adverse CV and metabolic outcomes particularly
in male offspring independent of background superovulation and ET
techniques. Our study shows a clear effect of culture duration after
IVF with long culture to the blastocyst stage before ET leading to a
poorer CV phenotype and shorter culture to the two-cell stage before
transfer resulting in a poorer metabolic health phenotype. We con-
sider this distinction in outcome likely reflects different pathways lead-
ing to these health conditions initiated from preimplantation
environment and the interaction between culture duration and the
timing of ET in relation to EGA. These findings further pinpoint the
risks of preimplantation manipulations in the programming of long-
term health outcomes. From a clinical perspective, whilst our data do
not identify a safer strategy for IVF and culture duration, they do show
the biological and health implications that derive from the ART culture
protocol.
Figure 8. Effect of ART techniques on organ/body weight in adult offspring. Organ allometry variables in male (A) and female (B); mean
(§SEM) organ: body weight ratio from 8 to 13 litters per treatment. Multilevel random effects regression analysis. *Indicates a significant difference
(P< 0.05) between NM and selected groups, D indicates IV-ET-2-Cell vs. IV-ET-BL, # indicates IV-ET-2Cell vs. IVF-ET-2Cell, and  indicates
IVF-ET-BL vs. IVF-ET-2Cell differences (P< 0.05). n mothers or foster mothers $, n offspring.
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